Sfoglia per Autore
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties
2008-01-01 CENA C.; CHEGAEV K; BALBO S; LAZZARATO L; ROLANDO B; GIORGIS M; MARINI E; FRUTTERO R; GASCO A
NO-donor aspirin derivatives
2009-01-01 Alberto Gasco; Roberta Fruttero; Loretta Lazzarato; Barbara Rolando; Konstantin Chegaev; Monica Donnola; Ennio Ongini; Stefano Biondi
Edaravone derivatives containing NO-donor functions
2009-01-01 Konstantin Chegaev; Clara Cena; Marta Giorgis; Barbara Rolando; Paolo Tosco; Massimo Bertinaria; Roberto Fruttero; Pier-Alain Carrupt; Alberto Gasco
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile
2009-01-01 Konstantin Chegaev; Loretta Lazzarato; Paolo Marcarino; Antonella Di Stilo; Roberta Fruttero; Nicolas Vanthuyne; Christian Roussel; Alberto Gasco.
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins
2009-01-01 Loretta Lazzarato; Monica Donnola; Barbara Rolando; Konstantin Chegaev; Elisabetta Marini; Clara Cena; Antonella Di Stilo; Roberta Fruttero; Stefano Biondi; Ennio Ongini; Alberto Gasco
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury
2009-01-01 Antonella Di Stilo; Konstantin Chegaev; Loretta Lazzarato; Roberta Fruttero; Alberto Gasco; Raffaella Rastaldo; Sandra Cappello
Unsymmetrically Substituted Furoxans. Part 19. Methyl and Phenylfuroxansulfonic Acids and Related Sulfonamides
2009-01-01 Konstantin Chegaev; Barbara Rolando; Stefano Guglielmo; Roberta Fruttero; Alberto Gasco
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors
2010-01-01 Roberta Fruttero; Loretta Lazzarato; Konstantin Chegaev; Barbara Rolando; Donatella Boschi; Claudiu T. Supuran; Alessio Innocenti; Alberto Gasco
PHENYLSULFONYL FUROXANS AS MODULATORS OF MULTIDRUGRESISTANCE-ASSOCIATED PROTEIN-1 AND P-GLYCOPROTEIN
2010-01-01 Fruttero R.; Crosetti M.; Chegaev K.; Guglielmo S.; Gasco A.; Berardi F.; Niso M.; Perrone R.; Panaro M. A.; Colabufo N. A.
Low concentrations of an nitric oxide-donor combined with a liposoluble antioxidant compound enhance protection against reperfusion injury in isolated rat hearts
2010-01-01 Rastaldo R; Cappello S; Folino A; Di Stilo A; Chegaev K; Tritto I; Pagliaro P; Losano G.
Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein
2010-01-01 Roberta Fruttero; Marco Crosetti; Konstantin Chegaev; Stefano Guglielmo; Alberto Gasco; Francesco Berardi; Mauro Niso; Roberto Perrone; Maria Antonietta Panaro; Nicola Antonio Colabufo
NO-Donor Cyanines As Potential Anti-Alzheimer Drugs
2011-01-01 Federico A.; Chegaev K.; Lazzarato L.; Marini E.; Fruttero R.; Gasco A.
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity
2011-01-01 Konstantin Chegaev; Chiara Riganti; Loretta Lazzarato; Barbara Rolando; Stefano Guglielmo; Ivana Campia; Roberta Fruttero; Amalia Bosia; Alberto Gasco
New nitric oxide or hydrogen sulfide releasing aspirins
2011-01-01 Loretta Lazzarato; Konstantin Chegaev; Elisabetta Marini; Barbara Rolando; Emily Borretto; Stefano Guglielmo; Sony Joseph; Antonella Di Stilo; Roberta Fruttero; Alberto Gasco
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs
2012-01-01 Barbara Rolando; Andrea Filieri; Konstantin Chegaev; Loretta Lazzarato; Marta Giorgis; Claudio De Nardi; Roberta Fruttero; Sophie Martel; Pierre-Alain Carrupt; Alberto Gasco
Multitarget drugs: NO-donor doxorubicins
2012-01-01 Chegaev K.; Riganti C.; Rolando B.; Federico A.; Fruttero R.; Gasco A.
Tolerance profile of new organic nitrates with antioxidant properties
2012-01-01 Di Stilo A.; Marini E.; Chegaev K.; Gasco A.
NITRIC OXIDE DONOR DOXORUBICINS: A USEFUL STRATEGY TO ADDRESS THE PROBLEM OF MDR IN CANCER THERAPY
2012-01-01 Rolando B.; Riganti C.; Chegaev K.; Fruttero R.; Gasco A.
Doxorubicin-antioxidant multitarget drugs
2013-01-01 K Chegaev; C Riganti; B Rolando; L Lazzarato; E Gazzano; S Guglielmo; D Ghigo; R Fruttero; A Gasco
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance.
2013-01-01 Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties | 2008 | CENA C.; CHEGAEV K; BALBO S; LAZZARATO L; ROLANDO B; GIORGIS M; MARINI E; FRUTTERO R; GASCO A | |
| NO-donor aspirin derivatives | 2009 | Alberto Gasco; Roberta Fruttero; Loretta Lazzarato; Barbara Rolando; Konstantin Chegaev; Monica Donnola; Ennio Ongini; Stefano Biondi | |
| Edaravone derivatives containing NO-donor functions | 2009 | Konstantin Chegaev; Clara Cena; Marta Giorgis; Barbara Rolando; Paolo Tosco; Massimo Bertinaria; Roberto Fruttero; Pier-Alain Carrupt; Alberto Gasco | |
| Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile | 2009 | Konstantin Chegaev; Loretta Lazzarato; Paolo Marcarino; Antonella Di Stilo; Roberta Fruttero; Nicolas Vanthuyne; Christian Roussel; Alberto Gasco. | |
| (Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins | 2009 | Loretta Lazzarato; Monica Donnola; Barbara Rolando; Konstantin Chegaev; Elisabetta Marini; Clara Cena; Antonella Di Stilo; Roberta Fruttero; Stefano Biondi; Ennio Ongini; Alberto Gasco | |
| Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury | 2009 | Antonella Di Stilo; Konstantin Chegaev; Loretta Lazzarato; Roberta Fruttero; Alberto Gasco; Raffaella Rastaldo; Sandra Cappello | |
| Unsymmetrically Substituted Furoxans. Part 19. Methyl and Phenylfuroxansulfonic Acids and Related Sulfonamides | 2009 | Konstantin Chegaev; Barbara Rolando; Stefano Guglielmo; Roberta Fruttero; Alberto Gasco | |
| NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors | 2010 | Roberta Fruttero; Loretta Lazzarato; Konstantin Chegaev; Barbara Rolando; Donatella Boschi; Claudiu T. Supuran; Alessio Innocenti; Alberto Gasco | |
| PHENYLSULFONYL FUROXANS AS MODULATORS OF MULTIDRUGRESISTANCE-ASSOCIATED PROTEIN-1 AND P-GLYCOPROTEIN | 2010 | Fruttero R.; Crosetti M.; Chegaev K.; Guglielmo S.; Gasco A.; Berardi F.; Niso M.; Perrone R.; Panaro M. A.; Colabufo N. A. | |
| Low concentrations of an nitric oxide-donor combined with a liposoluble antioxidant compound enhance protection against reperfusion injury in isolated rat hearts | 2010 | Rastaldo R; Cappello S; Folino A; Di Stilo A; Chegaev K; Tritto I; Pagliaro P; Losano G. | |
| Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein | 2010 | Roberta Fruttero; Marco Crosetti; Konstantin Chegaev; Stefano Guglielmo; Alberto Gasco; Francesco Berardi; Mauro Niso; Roberto Perrone; Maria Antonietta Panaro; Nicola Antonio Colabufo | |
| NO-Donor Cyanines As Potential Anti-Alzheimer Drugs | 2011 | Federico A.; Chegaev K.; Lazzarato L.; Marini E.; Fruttero R.; Gasco A. | |
| Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity | 2011 | Konstantin Chegaev; Chiara Riganti; Loretta Lazzarato; Barbara Rolando; Stefano Guglielmo; Ivana Campia; Roberta Fruttero; Amalia Bosia; Alberto Gasco | |
| New nitric oxide or hydrogen sulfide releasing aspirins | 2011 | Loretta Lazzarato; Konstantin Chegaev; Elisabetta Marini; Barbara Rolando; Emily Borretto; Stefano Guglielmo; Sony Joseph; Antonella Di Stilo; Roberta Fruttero; Alberto Gasco | |
| Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs | 2012 | Barbara Rolando; Andrea Filieri; Konstantin Chegaev; Loretta Lazzarato; Marta Giorgis; Claudio De Nardi; Roberta Fruttero; Sophie Martel; Pierre-Alain Carrupt; Alberto Gasco | |
| Multitarget drugs: NO-donor doxorubicins | 2012 | Chegaev K.; Riganti C.; Rolando B.; Federico A.; Fruttero R.; Gasco A. | |
| Tolerance profile of new organic nitrates with antioxidant properties | 2012 | Di Stilo A.; Marini E.; Chegaev K.; Gasco A. | |
| NITRIC OXIDE DONOR DOXORUBICINS: A USEFUL STRATEGY TO ADDRESS THE PROBLEM OF MDR IN CANCER THERAPY | 2012 | Rolando B.; Riganti C.; Chegaev K.; Fruttero R.; Gasco A. | |
| Doxorubicin-antioxidant multitarget drugs | 2013 | K Chegaev; C Riganti; B Rolando; L Lazzarato; E Gazzano; S Guglielmo; D Ghigo; R Fruttero; A Gasco | |
| Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. | 2013 | Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile